| Accession Number: | 0001213900-22-022766 |
| Date: | 2022-04-27 |
| Issuer: | ENZO BIOCHEM INC (ENZ) |
| Original Submission Date: |
RADOFF BRADLEY LOUIS
C/O ENZO BIOCHEM, INC.
527 MADISON AVENUE
NEW YORK, NY 10022
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK, $0.01 PAR VALUE | 2022-04-27 | A | 39,063 | a | $0.00 | 3,937,163 | direct | ||
| COMMON STOCK, $0.01 PAR VALUE | 2022-04-27 | 0 | $0.00 | 430,000 | indirect |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | the reporting person was granted restricted stock units that will vest, subject to the individual continuing to serve as a member of the board of directors of enzo biochem, inc., in two equal annual instalments, beginning on april 27, 2023. |
